WE CARE for Satisfaction, Patient

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Satisfaction, Patient+3 More
WE CARE - Behavioral
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help determine if providing families with resources can reduce stress and improve health outcomes.

Eligible Conditions
  • Satisfaction, Patient
  • Receipt of Community Resources
  • Provider Referrals
  • Basic Unmet Material Needs

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 8 Secondary · Reporting Duration: 1.5-,2-,and 2.5- years post-implementation of WE CARE

1.5-,2-,and 2.5- years post-implementation of WE CARE
Appropriate referrals made by providers
WE CARE survey distribution
3 months post-index visit
Care coordination measured via the National Survey of Children's Health (2016)
Family centeredness measured via the National Survey of Children's Health (2016)
Patient satisfaction measured via the CAHPS Clinician and Group Survey (Child)
Receipt of Community Resources
Baseline at Index visit
Provider Referrals for Unmet Material Needs at Visit
Baseline at index visit
Food Insecurity
Month 15
Acceptability of WE CARE measured via questionnaires
Appropriateness of WE CARE measured via questionnaire

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Usual Care-Control
1 of 3
On-site WE CARE implementation arm
1 of 3
Self-directed web-based WE CARE implementation arm
1 of 3
Active Control
Experimental Treatment

2520 Total Participants · 3 Treatment Groups

Primary Treatment: WE CARE · No Placebo Group · N/A

On-site WE CARE implementation arm
Behavioral
Experimental Group · 1 Intervention: WE CARE · Intervention Types: Behavioral
Self-directed web-based WE CARE implementation arm
Behavioral
Experimental Group · 1 Intervention: WE CARE · Intervention Types: Behavioral
Usual Care-ControlNoIntervention Group · 1 Intervention: Usual Care-Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1.5-,2-,and 2.5- years post-implementation of we care

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,806 Previous Clinical Trials
2,232,759 Total Patients Enrolled
Boston Medical CenterLead Sponsor
357 Previous Clinical Trials
874,591 Total Patients Enrolled
1 Trials studying Satisfaction, Patient
4 Patients Enrolled for Satisfaction, Patient
Boston UniversityOTHER
414 Previous Clinical Trials
10,025,446 Total Patients Enrolled
1 Trials studying Satisfaction, Patient
Continuity Research NetworkNETWORK
1 Previous Clinical Trials
27 Total Patients Enrolled
Pediatric Research in Office SettingsNETWORK
Arvin Garg, MD, MPHPrincipal InvestigatorUniversity of Massachusets Medical School
2 Previous Clinical Trials
536 Total Patients Enrolled

Eligibility Criteria

Age < 18 · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 19th, 2021

Last Reviewed: October 10th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.